Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study evaluated the safety of Aripiprazole Lauroxil for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluated the safety of Aripiprazole Lauroxil for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including CerritosThis study evaluated the safety and effectiveness of Paliperidone Palmitate for people with schizophrenia.
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockThis study evaluates the safety and effectiveness of Aticaprant for people with depression.
This study ended early.
Multiple locations, including HuntsvilleThis study evaluated the safety and effectiveness of Aticaprant for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamThis study evaluated the safety and effectiveness of Aticaprant for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including TucsonThis study evaluates the safety and effectiveness of Aticaprant for people with depression.
This study ended early.
Multiple locations, including BirminghamA Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia
This study ended early.
Multiple locations, including Little RockA Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behaviour Problems in Children With ASD
Read the official source — NCT00485849An Open Label Pilot Study of Atomoxetine for Attention Deficit and Hyperactive/Impulsive Behavior Problems in Children and Adolescents With Autistic Spectrum Disorders
This study has finished and is no longer accepting participants.
In GroningenA Phase II, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate Efficacy and Safety of RO4917838 in Combination With Selective Serotonin Reuptake Inhibitors in Patients With Obsessive Compulsive Disorder
This study has finished and is no longer accepting participants.
Multiple locations, including Oceanside
Effects of Traumatic Brain Injury and Post Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans Using Alzheimer's Disease Neuroimaging Initiative (ADNI)
This study has finished and is no longer accepting participants.
Multiple locations, including Sun CityThis study evaluated the safety and effectiveness of BRII-296 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Sherman OaksWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.